UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
Category: Cancer (Page 2)
Two new brain tumor medications could make a significant difference in the way tumors are treated — and in the lives of patients.
Learn how her research could lead to new and better life-saving treatments for ovarian and pancreatic cancers.
Endobiliary ablation can extend survival for patients with conditions like cholangiocarcinoma and pancreatic cancers.
A tool created by UVA Health researchers is identifying new treatments for heart failure in drugs approved by the FDA for blood cancer.
Michael E. Williams, MD, is a hematology/oncology researcher at UVA Health, exploring ways to reduce chemotherapy use in blood cancer.
UVA Health launches 2 key clinical trials to see if immunotherapy combined with FUS tumor ablation can prevent breast cancer metastasis.
These procedures offer minimally invasive options for many conditions, including early gastrointestinal cancers.
With a first-of-its-kind focused ultrasound center & trials, UVA Health is positioned to overcome immunotherapy’s cancer-metastases limitation.
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.